Compounds > 2,2-bis(4-glycidyloxyphenyl)propane
Page last updated: 2024-10-23

2,2-bis(4-glycidyloxyphenyl)propane and Bone Loss, Osteoclastic

2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Bone Loss, Osteoclastic in 1 studies

2,2-bis(4-glycidyloxyphenyl)propane: structure

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Y1
Pan, Z1
Chen, F1

Other Studies

1 other study available for 2,2-bis(4-glycidyloxyphenyl)propane and Bone Loss, Osteoclastic

ArticleYear
Inhibition of PPARĪ³ by bisphenol A diglycidyl ether ameliorates dexamethasone-induced osteoporosis in a mouse model.
    The Journal of international medical research, 2019, Volume: 47, Issue:12

    Topics: Adipogenesis; Adiposity; Animals; Benzhydryl Compounds; Biomarkers; Bone Marrow; Bone Resorption; Co

2019